Consun Pharmaceutical (01681) Announces Share Repurchases Without Changing Issued Share Capital

Bulletin Express

2025/10/23

Consun Pharmaceutical Group Limited (01681) issued a Next Day Disclosure Return regarding share repurchases from 14 October 2025 to 23 October 2025. A total of 2,011,000 shares were repurchased at prices ranging from approximately HKD 14.91 to HKD 15.76 per share. Since the repurchased shares were not yet canceled as of 23 October 2025, the issued share capital remained at 847,973,407 shares.

During this period, 422,000 shares were repurchased on 23 October 2025 for an aggregate price of HKD 6,294,050. These transactions fell under a repurchase mandate granted on 22 May 2025, authorizing up to 85,126,334 shares to be bought back, equivalent to 8.4651% of the Company’s issued shares as of that date. A 30-day moratorium on new share issuances or treasury share sales is in effect until 22 November 2025.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1150779809"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1150779809\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1150779809?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-23 19:59","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1150779809","market":"hk","top_or_hot":-1,"title":"Consun Pharmaceutical (01681) Announces Share Repurchases Without Changing Issued Share Capital","media":"Bulletin Express","content":"<p>Consun Pharmaceutical Group Limited (01681) issued a Next Day Disclosure Return regarding share repurchases from 14 October 2025 to 23 October 2025. A total of 2,011,000 shares were repurchased at prices ranging from approximately HKD 14.91 to HKD 15.76 per share. Since the repurchased shares were not yet canceled as of 23 October 2025, the issued share capital remained at 847,973,407 shares.</p>\n<p>During this period, 422,000 shares were repurchased on 23 October 2025 for an aggregate price of HKD 6,294,050. These transactions fell under a repurchase mandate granted on 22 May 2025, authorizing up to 85,126,334 shares to be bought back, equivalent to 8.4651% of the Company’s issued shares as of that date. A 30-day moratorium on new share issuances or treasury share sales is in effect until 22 November 2025.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Consun Pharmaceutical (01681) Announces Share Repurchases Without Changing Issued Share Capital</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nConsun Pharmaceutical (01681) Announces Share Repurchases Without Changing Issued Share Capital\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time smaller\">2025-10-23 19:59</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Consun Pharmaceutical Group Limited (01681) issued a Next Day Disclosure Return regarding share repurchases from 14 October 2025 to 23 October 2025. A total of 2,011,000 shares were repurchased at prices ranging from approximately HKD 14.91 to HKD 15.76 per share. Since the repurchased shares were not yet canceled as of 23 October 2025, the issued share capital remained at 847,973,407 shares.</p>\n<p>During this period, 422,000 shares were repurchased on 23 October 2025 for an aggregate price of HKD 6,294,050. These transactions fell under a repurchase mandate granted on 22 May 2025, authorizing up to 85,126,334 shares to be bought back, equivalent to 8.4651% of the Company’s issued shares as of that date. A 30-day moratorium on new share issuances or treasury share sales is in effect until 22 November 2025.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01681","symbol_name":"康臣藥業","start_time":0,"source_url":"","article_id":"1150779809","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1150779809","pubTimestamp":1761220773,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Consun Pharmaceutical Group Limited (01681) issued a Next Day Disclosure Return regarding share repurchases from 14 October 2025 to 23 October 2025. A total of 2,011,000 shares were repurchased at...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01681":"康臣药业"},"translate_title":"康臣药业(01681)公布购回股份而不改变已发行股本","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01681":1},"content_text":"Consun Pharmaceutical Group Limited (01681) issued a Next Day Disclosure Return regarding share repurchases from 14 October 2025 to 23 October 2025. A total of 2,011,000 shares were repurchased at prices ranging from approximately HKD 14.91 to HKD 15.76 per share. Since the repurchased shares were not yet canceled as of 23 October 2025, the issued share capital remained at 847,973,407 shares.\nDuring this period, 422,000 shares were repurchased on 23 October 2025 for an aggregate price of HKD 6,294,050. These transactions fell under a repurchase mandate granted on 22 May 2025, authorizing up to 85,126,334 shares to be bought back, equivalent to 8.4651% of the Company’s issued shares as of that date. A 30-day moratorium on new share issuances or treasury share sales is in effect until 22 November 2025.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}